CD274 and urothelial carcinoma: The immune landscape of the tumor microenvironment of urothelial carcinoma, including the infiltration level of immune cells, cytokine secretion, and PD-L1 expression, is associated with the ICI-treated response of patients with UC and other cancers (5).